Ibrance 75 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DB25FFQTB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,124
Award facts
- Contract value 100% obligated
- $8,123.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ibrance 75 mg tablets in packages of seven units, with a ceiling value of $8,123.96 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 10, 2025, and performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The broader SPE2DX IDC encompasses a wide range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order for Ibrance, an oncology medication, exemplifies the company's role in supplying specialized pharmaceutical products to federal healthcare systems through the DLA's established procurement framework.
Quick answers
Who was awarded contract SPE2DB25FFQTB?
SPE2DB25FFQTB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FFQTB worth?
The government has obligated $8,124 on SPE2DB25FFQTB.
Is contract SPE2DB25FFQTB an order under another contract?
Yes. SPE2DB25FFQTB is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFQTB competed?
The extent of competition for SPE2DB25FFQTB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award